BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27644661)

  • 1. BRCA1 and TP53 Gene-Mutations: Family Predisposition and Radioecological Risk of Developing Breast Cancer.
    Apsalikov B; Manambaeva Z; Ospanov E; Massabayeva M; Zhabagin K; Zhagiparova Z; Maximov V; Voropaeva E; Apsalikov K; Belikhina T; Abdrahmanov R; Cherepkova E; Tanatarov S; Massadykov A; Urazalina N
    Asian Pac J Cancer Prev; 2016; 17(8):4059-62. PubMed ID: 27644661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of polymorphisms in codons 11, 72 and 248 of TP53 in Brazilian women with breast cancer.
    Almeida BC; Kleine JP; Camargo-Kosugi CM; Lisboa MR; França CN; França JP; Silva ID
    Genet Mol Res; 2016 Feb; 15(1):. PubMed ID: 26909997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coordination of TP53 abnormalities in breast cancer: data from analysis of TP53 polymorphisms, loss of heterozygosity, methylation, and mutations.
    Denisov EV; Sukhanovskaya TV; Dultseva TS; Malinovskaya EA; Litviakov NV; Slonimskaya EM; Choinzonov EL; Cherdyntseva NV
    Genet Test Mol Biomarkers; 2011 Dec; 15(12):901-7. PubMed ID: 21810023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-risk human papilloma virus infection, tumor pathophenotypes, and BRCA1/2 and TP53 status in juvenile breast cancer.
    Aceto GM; Solano AR; Neuman MI; Veschi S; Morgano A; Malatesta S; Chacon RD; Pupareli C; Lombardi M; Battista P; Marchetti A; Mariani-Costantini R; Podestà EJ
    Breast Cancer Res Treat; 2010 Aug; 122(3):671-83. PubMed ID: 19851859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline TP53 mutation spectrum in Sudanese premenopausal breast cancer patients: correlations with reproductive factors.
    Aceto GM; Awadelkarim KD; Di Nicola M; Moscatello C; Pantalone MR; Verginelli F; Elwali NE; Mariani-Costantini R
    Breast Cancer Res Treat; 2019 Jun; 175(2):479-485. PubMed ID: 30796655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent TP53 missense mutation in cancer patients of Arab descent.
    Zick A; Kadouri L; Cohen S; Frohlinger M; Hamburger T; Zvi N; Plaser M; Avital E; Breuier S; Elian F; Salah A; Goldberg Y; Peretz T
    Fam Cancer; 2017 Apr; 16(2):295-301. PubMed ID: 27866339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of pathogenic mutations in patients with early-onset breast cancer by family history.
    Lalloo F; Varley J; Ellis D; Moran A; O'Dair L; Pharoah P; Evans DG;
    Lancet; 2003 Mar; 361(9363):1101-2. PubMed ID: 12672316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.
    Walsh T; Casadei S; Coats KH; Swisher E; Stray SM; Higgins J; Roach KC; Mandell J; Lee MK; Ciernikova S; Foretova L; Soucek P; King MC
    JAMA; 2006 Mar; 295(12):1379-88. PubMed ID: 16551709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers.
    Palanca Suela S; Esteban Cardeñosa E; Barragán González E; de Juan Jiménez I; Chirivella González I; Segura Huerta A; Guillén Ponce C; Martínez de Dueñas E; Montalar Salcedo J; Castel Sánchez V; Bolufer Gilabert P;
    Breast Cancer Res Treat; 2010 Jan; 119(1):87-93. PubMed ID: 19214744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genotyping of BRCA1, BRCA2 and CHEK2 germline mutations in Russian breast cancer patients using diagnostic biochips].
    Nasedkina TV; Gromyko OE; Emel'ianova MA; Ignatova EO; Kazubskaia TP; Portnoĭ SM; Zasedatelev AS; Liubchenko LN
    Mol Biol (Mosk); 2014; 48(2):243-50. PubMed ID: 25850293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Association of murine double minute 2 and P53 polymorphisms with breast cancer susceptibility].
    Wang ML; Xu YX; Qian J; Wang FH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Feb; 47(2):124-8. PubMed ID: 23719102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 72Pro Variant of the Tumor Protein 53 Is Associated with an Increased Breast Cancer Risk in the Moroccan Population.
    Ayoubi SE; Elkarroumi M; El Khachibi M; Hassani Idrissi H; Ayoubi H; Ennachit S; Arazzakou M; Nadifi S
    Pathobiology; 2018; 85(4):247-253. PubMed ID: 29949804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of novel mutations in BRCA1 in Iranian families with breast cancer.
    Sadr-Nabavi A; Dastpak M; Homaei-Shandiz F; Bahrami AR; Bidkhori HR; Raeesolmohaddeseen M
    Hereditas; 2014 Jun; 151(2-3):38-42. PubMed ID: 25041116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Population genetic analysis of the association between the BRCA1 and P53 gene polymorphisms and the risk of sporadic breast cancer].
    Tarasov VA; Aslanian MM; Tsyrendorzhieva ES; Gar'kavtseva RF; Liubchenko LN; Altukhov IuP; Mel'nik VA
    Genetika; 2005 Aug; 41(8):1115-24. PubMed ID: 16161633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crosstalk between the FGFR2 and TP53 genes in breast cancer: data from an association study and epistatic interaction analysis.
    Cherdyntseva NV; Denisov EV; Litviakov NV; Maksimov VN; Malinovskaya EA; Babyshkina NN; Slonimskaya EM; Voevoda MI; Choinzonov EL
    DNA Cell Biol; 2012 Mar; 31(3):306-16. PubMed ID: 21838531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant association of BRCA1 (rs1799950), BRCA2 (rs144848) and TP53 (rs1042522) polymorphism with breast cancer risk in Pashtun population of Khyber Pakhtunkhwa, Pakistan.
    Khan Y; Khan NU; Ali I; Khan S; Khan AU; Iqbal A; Adams BD
    Mol Biol Rep; 2023 Jul; 50(7):6087-6096. PubMed ID: 37300745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of GPRC5A germline mutations in BRCA1-mutant breast cancer patients.
    Sokolenko AP; Bulanova DR; Iyevleva AG; Aleksakhina SN; Preobrazhenskaya EV; Ivantsov AO; Kuligina ESh; Mitiushkina NV; Suspitsin EN; Yanus GA; Zaitseva OA; Yatsuk OS; Togo AV; Kota P; Dixon JM; Larionov AA; Kuznetsov SG; Imyanitov EN
    Int J Cancer; 2014 May; 134(10):2352-8. PubMed ID: 24470238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequency of BRCA1 5382insC mutation in Russian breast cancer patients.
    Sokolenko AP; Mitiushkina NV; Buslov KG; Bit-Sava EM; Iyevleva AG; Chekmariova EV; Kuligina ESh; Ulibina YM; Rozanov ME; Suspitsin EN; Matsko DE; Chagunava OL; Trofimov DY; Devilee P; Cornelisse C; Togo AV; Semiglazov VF; Imyanitov EN
    Eur J Cancer; 2006 Jul; 42(10):1380-4. PubMed ID: 16737811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers.
    Wang WW; Spurdle AB; Kolachana P; Bove B; Modan B; Ebbers SM; Suthers G; Tucker MA; Kaufman DJ; Doody MM; Tarone RE; Daly M; Levavi H; Pierce H; Chetrit A; Yechezkel GH; Chenevix-Trench G; Offit K; Godwin AK; Struewing JP
    Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):955-60. PubMed ID: 11535547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA1 and TP53 mutation spectrum of breast carcinoma in an ethnic population of Kashmir, an emerging high-risk area.
    Eachkoti R; Hussain I; Afroze D; Aejazaziz S; Jan M; Shah ZA; Das BC; Siddiqi MA
    Cancer Lett; 2007 Apr; 248(2):308-20. PubMed ID: 16996204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.